HUBEI BOZ PHARM&CHEM CO., LTD.

Product Certification

HUBEI BOZ PHARM&CHEM CO., LTD.

Country:China (Mainland)

Business Type:Lab/Research institutions

qq

    x
  • Ms.Irene

Contacts

  • Mr.bozchem
    Tel: 86-13296555120

  • Ms.Irene
    Tel: +86 18271850054

  • Fax: 86-4008266163-20866
  • Province/state: Hubei
  • City: Wuhan
  • Street:Plot no.62-4, Tangshan industrial park, Wuhan, China
E-MAIL Supplier    Clike here
Home > Products > 

AZD9291

AZD9291 CAS NO.1421373-65-0

  • FOB Price: USD: 100.00-100.00 /Metric Ton Get Latest Price
  • Min.Order: 10 Gram
  • Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
  • Available Specifications:

    Enterprise Standard(1-100)Metric Ton

  • Product Details

Keywords

  • AZD9291
  • Osimertinib
  • AZD-9291 1421373-65-0

Quick Details

  • ProName: AZD9291
  • CasNo: 1421373-65-0
  • Molecular Formula: C28H33N7O2
  • Appearance: White powder
  • Application: Ramelteon is a sleep agent that select...
  • DeliveryTime: Immediately
  • PackAge: Fluoride bottle or as required
  • Port: Shanghai, Hongkong, Shenzhen
  • ProductionCapacity: 30 Metric Ton/Day
  • Purity: 99%
  • Storage: Store in a cool and dry area, keep sea...
  • Transportation: As required.
  • LimitNum: 10 Gram
  • Related Substances: ≤0.2%
  • Residue on Ignition: 0.05%
  • Heavy Metal: ≤20ppm
  • Valid Period: 2 years
  • Other Names: Osimertinib; mereletinib
  • CAS No: 1421373-65-0
  • Molecular Formula: C28H33N7O2
  • Molecular Weight: 499.607
  • Purity: 99%

Superiority

1.High quality

2.High purity 

3.Best price

4.Best service

5.Professional manufacturer

6.Loyal and honest supplier 

7.Fast response to customer within 6 hours

 

Product Name: AZD9291

Other Names: Osimertinib; mereletinib

CAS No: 1421373-65-0

Molecular Formula: C28H33N7O2

Molecular Weight: 499.607

Purity: 99%

Appearance: white powder

Osimertinib (previously known as mereletinib or AZD9291; trade name Tagrisso) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug developed by AstraZeneca Pharmaceuticals – for mutated EGFR cancers.

Details

Product Name: AZD9291

Other Names: Osimertinib; mereletinib

CAS No: 1421373-65-0

Molecular Formula: C28H33N7O2

Molecular Weight: 499.607

Purity: 99%

Appearance: white powder

Osimertinib (previously known as mereletinib or AZD9291; trade name Tagrisso) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug developed by AstraZeneca Pharmaceuticals – for mutated EGFR cancers.

 

 

Product Name: AZD-9291 Batch No.: BOZ/AZD/17/Jan/06                  
CAS No.: 1421373-65-0 Quantity: 4KG
Manufacturing Date: Jan., 6th, 2017 Text Date: Jan., 7th, 2017
Expiry Date:  Jan., 5th, 2019 Quality Standard: Enterprise Standard
TEST SPECIFICATION RESULT
 Physical Characters
Appearance White powder Conforms  
Identification The retention time of text sample major peak conforms to reference standard. Conforms
 Impurities
single impurity

≤0.2%

0.18%

Chemical Characters
Heavy Metals ≤20PPM Conforms

Residue on Ignition

≤0.2%

0.05%

Loss on Drying ≤0.5% 0.13%
Solvent residue

Dioxane≤380ppm

Acetone≤5000ppm

Acetonitrile≤410ppm

Not detected

482ppm

22ppm

Assay (by HPLC) 98.5% min. 99.81%

Packing - Fluoride bottle or as required.

Storage - Store in well closed container away from oxides and acids.

Conclusion: The above analysis results comply with the specification. Customer is advised to verify the results before use.

 

 

 

 

 

 

 

 

 

 

Other products of this supplier

HUBEI BOZ PHARM&CHEM CO., LTD.Tel:86-13296555120 Fax:86-4008266163-20866  Email:bens@bozchem.com
 Address:Plot no.62-4, Tangshan industrial park, Wuhan, China